This company seems to have been delisted
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Reason: Shutdown after failing to find a buyer
Last recorded trade on: February 24, 2023
Source: https://www.fiercebiotech.com/biotech/genocea-closes-shop-after-failing-find-buyer-delists-nasdaq
Genocea Biosciences
GNCA
$0.0001432
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Earnings for Genocea Biosciences (GNCA)
Earnings in 2022 (TTM): -C$46.84 Million
According to Genocea Biosciences 's latest financial reports the company's current earnings are C$1.91 Million. In 2021 the company made an earning of -C$47.53 Million, an increase over its 2020 earnings that were of -C$62.59 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genocea Biosciences from 2013 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -C$46.84 Million | -1.46% |
| 2021 | -C$47.53 Million | -24.06% |
| 2020 | -C$62.59 Million | 12.23% |
| 2019 | -C$55.77 Million | 40.05% |
| 2018 | -C$39.82 Million | -50.96% |
| 2017 | -C$81.2 Million | 14.4% |
| 2016 | -C$70.98 Million | 16.69% |
| 2015 | -C$60.83 Million | 20.36% |
| 2014 | -C$50.54 Million | 69.64% |
| 2013 | -C$29.79 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -C$0.14 Billion | 149.86% | 🇺🇸 USA |
 | -C$0.23 Billion | 320.91% | 🇺🇸 USA |
 | C$30.36 B | -57,121.86% | 🇺🇸 USA |
 | -C$20.06 Million | -62.33% | 🇺🇸 USA |
 | C$15.91 B | -29,980.89% | 🇺🇸 USA |